Respiratory viruses in acute otitis media

被引：14

作者：

Eskola, J ^{[1
]}

Hovi, T ^{[1
]}

机构：

[1] Natl Publ Hlth Inst, Helsinki, Finland

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 04期

关键词：

D O I：

10.1056/NEJM199901283400412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：312 / 314

页数：3

共 13 条

[1] The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].

Belshe, RB ;

Mendelman, PM ;

Treanor, J ;

King, J ;

Gruber, WC ;

Piedra, P ;

Bernstein, DI ;

Hayden, FG ;

Kotloff, K ;

Zangwill, K ;

Iacuzio, D ;

Wolff, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412

[2] INFLUENZA-A VACCINE DECREASES THE INCIDENCE OF OTITIS-MEDIA IN 6- TO 30-MONTH-OLD CHILDREN IN DAY-CARE [J].

CLEMENTS, DA ;

LANGDON, L ;

BLAND, C ;

WALTER, E .

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (10) :1113-1117

[3] Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia [J].

Groothuis, JR ;

King, SJ ;

Hogerman, DA ;

Paradiso, PR ;

Simoes, EAF .

JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) :467-469

[4] Prevalence of various respiratory viruses in the middle ear during acute otitis media [J].

Heikkinen, T ;

Thint, M ;

Chonmaitree, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :260-264

[5] INFLUENZA VACCINATION IN THE PREVENTION OF ACUTE OTITIS-MEDIA IN CHILDREN [J].

HEIKKINEN, T ;

RUUSKANEN, O ;

WARIS, M ;

ZIEGLER, T ;

AROLA, M ;

HALONEN, P .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1991, 145 (04) :445-448

[6] A LONGITUDINAL-STUDY OF RESPIRATORY VIRUSES AND BACTERIA IN THE ETIOLOGY OF ACUTE OTITIS-MEDIA WITH EFFUSION [J].

HENDERSON, FW ;

COLLIER, AM ;

SANYAL, MA ;

WATKINS, JM ;

FAIRCLOUGH, DL ;

CLYDE, WA ;

DENNY, FW .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (23) :1377-1383

[7] Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children [J].

Karron, RA ;

Wright, PF ;

Crowe, JE ;

ClementsMann, ML ;

Thompson, J ;

Makhene, M ;

Casey, R ;

Murphy, BR .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1428-1436

[8] PRESENCE OF RESPIRATORY SYNCYTIAL VIRUS GENOMIC SEQUENCES IN MIDDLE-EAR FLUID AND ITS RELATIONSHIP TO EXPRESSION OF CYTOKINES AND CELL-ADHESION MOLECULES [J].

OKAMOTO, Y ;

KUDO, K ;

ISHIKAWA, K ;

ITO, E ;

TOGAWA, K ;

SAITO, I ;

MORO, I ;

PATEL, JA ;

OGRA, PL .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05) :1277-1281

[9] SAFETY AND IMMUNOGENICITY OF A SUBUNIT RESPIRATORY SYNCYTIAL VIRUS-VACCINE IN CHILDREN 24 TO 48 MONTHS OLD [J].

PARADISO, PR ;

HILDRETH, SW ;

HOGERMAN, DA ;

SPEELMAN, DJ ;

LEWIN, EB ;

OREN, J ;

SMITH, DH .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (09) :792-798

[10] Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis [J].

Piedra, PA ;

Grace, S ;

Jewell, A ;

Spinelli, S ;

Bunting, D ;

Hogerman, DA ;

Malinoski, F ;

Hiatt, PW .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (01) :23-31

← 1 2 →